Nash, R. A., Kraft, G. H., Bowen, J. D., McSweeney, P. A., Pavletic, S., Al-Omaishi, J., … Sullivan, K. M. (2000). Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT). BLOOD, 96(11), 842A-843A.

Nash, R. A., G. H. Kraft, J. D. Bowen, P. A. McSweeney, S. Pavletic, J. Al-Omaishi, J. R. Corboy, et al. “Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT).” BLOOD 96, no. 11 (November 16, 2000): 842A-843A.

Nash RA, Kraft GH, Bowen JD, McSweeney PA, Pavletic S, Al-Omaishi J, et al. Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT). BLOOD. 2000 Nov 16;96(11):842A-843A.

Nash, R. A., et al. “Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT).” BLOOD, vol. 96, no. 11, AMER SOC HEMATOLOGY, Nov. 2000, pp. 842A-843A.

Nash RA, Kraft GH, Bowen JD, McSweeney PA, Pavletic S, Al-Omaishi J, Corboy JR, Holmberg LA, Openshaw H, Prather K, Ryan K, Storek J, Zunt JR, Sullivan KM. Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT). BLOOD. AMER SOC HEMATOLOGY; 2000 Nov 16;96(11):842A-843A.